Evaluation of clinical disintegration time and palatability of orally disintegrating tablets of rebamipide

Evaluation of clinical disintegration time and palatability of orally disintegrating tablets of rebamipide - Evaluation of clinical disintegration time and palatability of orally disintegrating tablets of rebamipide

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000023380

Enrollment

Registered

2016-07-28

Start date

2014-08-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healhy volunteea

Interventions

rebamipide ODT without taste-masking rebamipide ODT with sweeteners rebamipide ODT with sweeteners and cocoa powder(2.5%) rebamipide ODT with sweeteners and cocoa powder(5%) rebamipide ODT with sweet

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: healthy adult (male and female)

Exclusion criteria

Exclusion criteria: 1. clearly taste disorder 2. allegy for drugs 3. pregnant and/or lactating women 4. other who was decided as inadequate by doctor

Design outcomes

Primary

Measure	Time frame
1. disintegration time 2. palatability (visual analogue scale) 3. acceptableness	—

Countries

Japan

Contacts

Public ContactAkio Hakamata

Hamamatsu University School of Medicine Department of Clinical Pharmacology and Therapetics

hakamata@hama-med.ac.jp053-435-2385

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026